Clinical Outcomes and Management of Inflammatory Bowel Disease in the Older Patient

Inflammatory Bowel Disease (SB Hanauer, Section Editor)

DOI: 10.1007/s11894-012-0310-4

Cite this article as:
Ha, C.Y. & Katz, S. Curr Gastroenterol Rep (2013) 15: 310. doi:10.1007/s11894-012-0310-4
Part of the following topical collections:
  1. Topical Collection on Inflammatory Bowel Disease


The management of inflammatory bowel disease in the older patient extends beyond the gastrointestinal tract. Pre-existing comorbidities, polypharmacy, functional status and physical reserve can impact disease course, response to therapy and quality of life. Current therapeutic endpoints may not be as immediately applicable to the older IBD patient at higher risk for adverse outcomes. This review focuses on the latest studies addressing the natural history, clinical course and therapeutic outcomes among the older IBD cohort.


Elderly Crohn’s disease Ulcerative colitis Polypharmacy Comorbidity Serious infection Mortality Morbidity Lymphoma Nonmelanoma skin cancer Colorectal cancer 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Meyerhoff Inflammatory Bowel Disease Center, Division of Gastroenterology and HepatologyBaltimoreUSA
  2. 2.North Shore University Hospital, Long Island Jewish Health Systems, St Francis HospitalGreat NeckUSA

Personalised recommendations